“…For example, crisprTF-based platforms enable bi-directional gene activation and repression in eukaryotic systems (Chavez et al, 2015; Farzadfard et al, 2013; Gilbert et al, 2013; Mali et al, 2013; Nishimasu et al, 2014; Zalatan et al, 2015) and have been used for genome-wide targeted screens owing to the ease of designing and synthesizing guide RNAs (gRNAs) (Gilbert et al, 2014; Horlbeck et al, 2016; Konermann et al, 2015). In addition, strategies for higher-order perturbations using barcoded combinatorial genetic screens in human cells have been adapted to be compatible with CRISPR-Cas9 screens (Wong et al, 2015; Wong et al, 2016). Existing CRISPR-Cas9-based screening strategies rely on gRNAs designed to target individual genes while minimizing off-target effects (Cencic et al, 2014; Frock et al, 2015; Gilbert et al, 2014; O'Geen et al, 2015; Parnas et al, 2015; Shalem et al, 2014; Wang et al, 2014; Wu et al, 2014).…”